Failure of low‐dose intravenous immunoglobulin therapy to suppress disease activity in patients with treatment‐refractory rheumatoid arthritisKeith S. Kanik, Ronald L. Wilder, Yaakov Naparstek et al.|Arthritis & Rheumatism|1996Cited by 26